Ahmed Wesal, Farida Hesham, Mohamed A M Gad, Mostafa Abdelrahim, Nariman Ahmed Sayed, Nour Bahgat, Nour Allah Zaki, Aliaa Rehan Youssef
{"title":"Modalities and algorithms for generalized motor seizure detection and prediction: a scoping review.","authors":"Ahmed Wesal, Farida Hesham, Mohamed A M Gad, Mostafa Abdelrahim, Nariman Ahmed Sayed, Nour Bahgat, Nour Allah Zaki, Aliaa Rehan Youssef","doi":"10.1080/17434440.2026.2632757","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Generalized tonic - clonic seizures (GTCS) is a major cause of sudden unexpected death in epilepsy (SUDEP); thus, continuous monitoring is essential. Electroencephalography (EEG) is the diagnostic gold standard; however, non-EEG wearables have emerged as promising, user-friendly alternatives enhancing comfort, mobility, and social acceptance.</p><p><strong>Areas covered: </strong>This scoping review compared sensing modalities and computational methods used for seizure detection and prediction, identified effective sensor combinations, and highlighted current research gaps. Following PRISMA-ScR guidelines, Scopus, IEEE Xplore, and PubMed databases were searched up to 22 April 2025. Twenty-nine studies met inclusion criteria. For seizure detection, combining electrodermal activity (EDA) with motion sensors - accelerometers (ACC) and gyroscopes (GYR) - and surface electromyography (sEMG) achieved high reliability, 98.6% precision, while using ACC and EDA alone yielded superior sensitivities up to 97.2% and a lower false alarm rate (FAR) of 0.53/24 h. Regarding seizure prediction, combining EDA, blood volume pulse (BVP), ACC, and temperature showed the highest sensitivity of 75.6%.</p><p><strong>Expert opinion: </strong>Wearable multimodal non-EEG seizure detection and prediction systems offer personalized care but face validation, hardware, and privacy hurdles. Future success depends on efficient AI, IoT integration, patient-centric design, and clear regulations ensuring accessible and trustworthy clinical tools.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":" ","pages":"409-424"},"PeriodicalIF":2.7000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert review of medical devices","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17434440.2026.2632757","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/2 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Generalized tonic - clonic seizures (GTCS) is a major cause of sudden unexpected death in epilepsy (SUDEP); thus, continuous monitoring is essential. Electroencephalography (EEG) is the diagnostic gold standard; however, non-EEG wearables have emerged as promising, user-friendly alternatives enhancing comfort, mobility, and social acceptance.
Areas covered: This scoping review compared sensing modalities and computational methods used for seizure detection and prediction, identified effective sensor combinations, and highlighted current research gaps. Following PRISMA-ScR guidelines, Scopus, IEEE Xplore, and PubMed databases were searched up to 22 April 2025. Twenty-nine studies met inclusion criteria. For seizure detection, combining electrodermal activity (EDA) with motion sensors - accelerometers (ACC) and gyroscopes (GYR) - and surface electromyography (sEMG) achieved high reliability, 98.6% precision, while using ACC and EDA alone yielded superior sensitivities up to 97.2% and a lower false alarm rate (FAR) of 0.53/24 h. Regarding seizure prediction, combining EDA, blood volume pulse (BVP), ACC, and temperature showed the highest sensitivity of 75.6%.
Expert opinion: Wearable multimodal non-EEG seizure detection and prediction systems offer personalized care but face validation, hardware, and privacy hurdles. Future success depends on efficient AI, IoT integration, patient-centric design, and clear regulations ensuring accessible and trustworthy clinical tools.